Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Liujing Xing, Ph.D.

Tech Specialist, Patent Agent

Boston, MA
617-521-7804
[email protected]
Download vCard
Liujing Xing, Ph.D. Photo

Background

 

Dr. Liujing Xing is a Technology Specialist, Patent Agent in the Boston office of Fish & Richardson. Her practice focuses on U.S. and foreign patent prosecution and strategic counseling in life sciences. She also provides assistance with opinion work, due diligence, freedom-to-operate, and patent landscape review. Technical areas of Dr. Xing’s prosecution work include biochemistry, molecular biology, molecular screening and diagnostics, genome editing techniques, antibody therapeutics, stem cell therapies and cancer therapies.

Dr. Xing received her Ph.D. in developmental biology from Stanford University. Her doctoral research focused on cell signaling pathways and the molecular regulation of neural stem cells.

Education

Stanford University 2017
Developmental Biology, Ph.D.


SUNY at Stony Brook University 2011
Biology, B.S.


Nanjing University 2011
Biology, B.S.

Admissions

  • U.S. Patent and Trademark Office 2018

Language

  • English
  • Mandarin Chinese

Other Distinctions

Publications

Xing L, Anbarchian T, Tsai JM, Plant GW, Nusse R. “Wnt/B-catenin signaling regulates ependymal cell development and adult homeostasis” Proceedings of the National Academy of Sciences 2018 Jun 26; 115(26): E5954-E5962.

Tsai JM, Koh PW, Stefanaska A, Xing L, Walmsley GG, Poux N, Weissman IL, Rinkevich Y, “Localized Hepatic Lobular Regeneration by Central Vein Associated Lineage-Restricted Progenitors” Proceedings of the National Academy of Sciences 2017 Apr 4; 114(14): 3654-3659.

Tsai, JM, Sinha R, Seita J, Fernhoff NB, Christ S, Koopmans T, Krampitz GW, McKenna KM, Xing L, Sandholzer M, Sales JH, Shoham M, McCracken M, Joubert L, Gordon SR, Poux N, Wernig G, Norton JA, Weissman IL, Rinkevich Y, “Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markers” Science Translational Medicine 2018 Nov 28;10(469): eaan6735.

Services

Industries